The Saunders P345 compact polymer pneumatic actuator from Crane ChemPharma & Energy simplifies infrastructure.
The Saunders P345 compact polymer pneumatic actuator from Crane ChemPharma & Energy is designed to operate at 4.5 bar while maintaining closure performance of up to 10 bar at 100% pressure drop. The actuator will simplify plant infrastructure and provide a lower total cost of ownership compared to existing technologies, says the company. This performance is achieved within a compact dimensional envelope and at a 30% lighter weight compared to typical stainless-steel variants, reducing dead-leg between associated valves. The use of polyamide housing and a stainless-steel bonnet provides a robust interface ensuring product reliability. Capable of withstanding temperatures between -10 °C and 100°C, the actuator is available in sizes DN8 (0.25”) to DN100 (4”) in spring-to-close, spring-to-open, and double-acting modes of operation.
Source: Crane ChemPharma & Energy
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.